pharmaceutical industry
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Read More
Could it be COVID? Here are the symptoms to watch out for in 2024
COVID symptoms can be mild, severe, or nonexistent, according to the CDC—and can appear as late as two weeks after ...
GSK, Pfizer RSV shots must warn about rare paralysis risk
An analysis found nine excess cases of Guillain-Barré for every million doses given. Read More
Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
The “Shark Tank” investor and Cost Plus Drugs cofounder Dr. Alex Oshmyansky participated in a White House health care roundtable. ...
Mark Cuban says CEOs don’t understand their health care costs. Here’s what the Cost Plus Drugs cofounder’s mistakes have taught him
“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything ...
Mark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’
Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just pills.” Read More
Bird flu could merge with seasonal flu to make mutated virus that could spread among humans, CDC warns
The 2024–25 flu shot doesn’t prevent H5N1 bird flu but could play a pivotal role in preventing a pandemic. Read ...
A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen
Bayer told workers to self-organize last year as part of a plan to save €2 billion in costs by 2026. ...
Merck-AstraZeneca breast cancer drug Lynparza improves long-term survival, clinical trial shows
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in ...
